Previous Close | $18.54 |
Intrinsic Value | $2.48 |
Upside potential | -87% |
Data is not available at this time.
Healthpeak Properties, Inc. is a leading real estate investment trust (REIT) specializing in healthcare-related properties, including life science facilities, medical offices, and senior housing. The company generates revenue primarily through long-term leases with high-quality tenants such as research institutions, hospitals, and senior care operators. Its diversified portfolio is strategically located in high-demand markets, ensuring stable cash flows and occupancy rates. Healthpeak’s focus on mission-critical healthcare assets positions it as a resilient player in the REIT sector, benefiting from demographic trends like aging populations and increased biotech innovation. The company’s emphasis on life science labs—a high-growth segment—further strengthens its competitive edge. By maintaining strong tenant relationships and disciplined capital allocation, Healthpeak sustains its reputation as a reliable income generator with moderate growth potential.
Healthpeak reported revenue of $2.70 billion for FY 2024, with net income of $243.1 million, translating to diluted EPS of $0.36. Operating cash flow stood at $1.07 billion, reflecting efficient property management and lease execution. The absence of capital expenditures suggests a focus on optimizing existing assets rather than aggressive expansion. The company’s ability to convert revenue into cash flow underscores its operational discipline.
With an operating cash flow margin of approximately 40%, Healthpeak demonstrates strong earnings power. The REIT’s capital efficiency is evident in its ability to sustain dividends while managing a sizable debt load. The lack of capex indicates a mature portfolio, though reinvestment may be necessary to maintain competitiveness in evolving healthcare real estate markets.
Healthpeak’s balance sheet shows $119.8 million in cash against total debt of $9.02 billion, indicating significant leverage. However, the REIT’s stable cash flows and long-term lease structures mitigate liquidity risks. The debt level is typical for the sector but requires careful monitoring amid rising interest rates. Shareholders’ equity remains supported by high-quality assets.
The company’s growth is tied to organic lease escalations and selective acquisitions in life sciences. A dividend of $1.18 per share reflects a commitment to income-focused investors, though payout ratios should be evaluated against FFO sustainability. Demographic tailwinds in healthcare demand provide a favorable backdrop for steady, long-term growth.
Healthpeak’s valuation likely reflects its stable cash flows and sector tailwinds, though high leverage may temper multiples. Market expectations appear balanced, pricing in moderate growth with a focus on dividend reliability. Comparables in the healthcare REIT space suggest investor confidence in its niche positioning.
Healthpeak’s strategic advantages include its focus on recession-resistant healthcare assets and a diversified tenant base. The outlook remains positive, supported by secular demand for life science and medical office spaces. Challenges include debt management and competitive pressures in high-growth markets. Prudent capital allocation will be key to sustaining long-term value creation.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |